Support of homeostatic glial cell signaling: A novel therapeutic approach by propentofylline

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 337-347

  Schubert, Peter ^a   Ogata, Tadanori ^a   Rudolphi, Karl ^a,b   Marchini, Cristina ^a   McRae, Amanda ^a,c   Ferroni, Stefano ^a,d  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b SANOFI   (France)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; CALCIUM ION; CYCLIC AMP; METABOTROPIC RECEPTOR; PHOSPHODIESTERASE INHIBITOR; PROPENTOFYLLINE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ASTROCYTE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; GLIA CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MACROPHAGE; MICROGLIA; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0030725599     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48484.x     Document Type: Conference Paper

References (32)

1. SAIDO, T. et al. 1994. Spatial resolution of the primary β-amyloidogenic process induced in postischemic hippocampus. J. Biol. Chem. 269: 15253-15257.
2. PIKE, C. J. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563: 339-349.
3. ROGERS, J. et al. 1988. Expression of immune system associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobil. Aging 9: 339-349.
4. MORIOKA, T. et al. 1991. The microglial reaction in the rat dorsal hippocampus following forebrain ischemia. J. Cereb. Blood Flow Metab. 10: 850-859.
5. MCGEER, P. L. et al. 1989. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16: 516-527.
6. BANATI, R. B. et al. 1993. Cytotoxicity of microglia. Glia 7: 111-118.
7. MEDA, L. et al. 1995. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374: 647-650
8. GIULIAN, D. et al. 1986. Interleukin-1 of the central nervous sytem is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
9. DELEO, J. et al. 1987. Ischemia-induced neuronal cell death, calcium accumulation and glial response in the hippocampus of the gerbil and protection by the xanthine derivative HWA 285. J. Cereb. Blood Flow Metab. 7: 745-752.
10. SZATKOWSKI, M. et al. 1990. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348: 443-446.
11. FERRONI, S. et al. 1995. Two distinct inward rectifying conductances are expressed in cultured rat cortical astrocytes after long term dibutyryl-cyclic-AMP treatment. FEBS Lett. 267: 319-325.
12. NISHIZUKA, Y. 1986. Studies and perspectives of protein kinase C. Science 233: 305-312.
13. DIEMER, N. H. et al. 1994. AMPA receptor and metabotropic glutamate receptor mRNA expression after transient global ischemia in the rat. Pathophysiology 1(Suppl.): 107.
14. O'NEILL, C. O. et al. 1994. G-protein coupled signal transduction systems in the Alzheimer's disease brain. Biochem. Soc. Trans. 22: 167-171.
15. 2 receptors and nitrobenzythioinosine-sensitive nucleoside transporters: Quantitative autoradiographic analysis. Eur. J. Pharmacol. 202: 361-366.
16. MESKINI, N. et al. 1994. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 47: 781-788.
17. 2 adenosine receptor cooperation. Eur. J. Neurosci. 8: 1124-1131.
18. VAN CALKER, D. et al. 1979. Adenosine regulates via different types of receptors the accumulation of cAMP in cultured brain cells. J. Neurochem. 33: 999-1005.
19. SHINODA, J. et al. 1990. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol. 39: 1813-1816.
20. CRONSTEIN, B. N. et al. 1985. Adenosine: A physiological modulator of Superoxide anion generation by human neutrophils. J. Immunol. 135:1366-1371.
21. SCHUBERT, P. et al 1992. Reactive oxygen intermediates in microglial cells differentiating into brain macrophages: Depression by propentofyllme and relation to adenosine action. In Pharmacology of Cerebral Ischemia. J. Krieglstein & H. Oberpichler, Eds.: 461-467. Wiss. Verl. Ges. Stuttgart.
22. BANATI, R. et al. 1994. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J. Cereb. Blood Flow Metab. 14: 145-149.
23. SCHUBERT, P. et al. Depression of TNF-α release from microglial cells by adenosine and propentofylline. Proceedings "Brain 97." J. Cereb. Blood Flow Cell Metab. Suppl. In press.
24. SI, Q. et al. 1996. Adenosine and propentofylline inhibit phorbol ester-induced proliferation of cultured microglia. Exp. Neurol. 137: 345-349.
25. MCRAE, A. et al. 1997. Postischemic glial responses and amyloid accumulation are modified by propentofylline: A neuroprotective pharmacon for Alzheimer's disease? In Biology, Diagnosis and Therapeutics. K. Igbal, B. Winblad, T. Nishimura, M. Takeda & H. M. Wisniewski, Eds.: 759-767. John Wiley & Sons Ltd. England.
26. McRAE, A. et al. 1994. Propentofylline depresses amyloid and Alzheimer's CSF microglial antigens after ischemia. NeuroReport 5: 1193-1196.
27. DUX, E. et al. 1990. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res. 516: 248-253.
28. PARK, C. K. & K. A. RUDOLPHI. 1994. Antiischemic effect of propentofylline (HWA 285) against focal cerebral infarction in rats. Neurosci. Lett. 178: 235-238.
29. HUBER, M. et al. 1993. Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke. J. Cereb. Blood Cell Metab. 13: 526-530.
30. SCHUBERT, P. et al. 1994. Modulation of nerve and glial cell function by adenosine-Role in the development of ischemic brain damage. Int. J. Biochem. 26: 1227-1236.
31. RUDOLPHI, K. A. et al. 1992. Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol. Sci. 13: 439-445.
32. RUDOLPHI, K. & P. SCHUBERT. 1995. Purinergic interventions in traumatic and ischemic injury. In Novel Therapies for CNS Injuries. P. L. Peterson & J. W. Phillis, Eds.: 327-346. CRC Press. New York, London, Tokyo.